Dalfampridine Dalstep 10mg Extended Release Tablets
The First USFDA approved NEURO FUNCTIONAL MODIFIER to improve walking impairment in all types of Multiple Sclerosis.
Dalfampridine Dalstep 10mg is a new drug now available in India for managing the symptoms of Multiple Sclerosis. Significantly improves walking speed and restores functionality.
Better Pharmacokinetics
The First USFDA approved NEURO FUNCTIONAL MODIFIER to improve walking impairment in all types of Multiple Sclerosis.
Dalfampridine Dalstep 10mg is a new drug now available in India for managing the symptoms of Multiple Sclerosis. Significantly improves walking speed and restores functionality.
Better Pharmacokinetics
- Rapidly and completely absorbed from GIT
- 96% relative bioavailability
- Lower plasma protein binding (1-3%)
- Longer half life (6.4 hrs) & lower peak serum levels
- No interaction with CYP450 enzymes
- No drug interactions with commonly Rxed and Interferons
Dalfampridine DALSTEP Extended Release Tablet
No comments:
Post a Comment